tradingkey.logo

KORU Medical Systems Inc

KRMD

3.920USD

-0.030-0.76%
終値 09/25, 16:00ET15分遅れの株価
181.24M時価総額
損失額直近12ヶ月PER

KORU Medical Systems Inc

3.920

-0.030-0.76%
詳細情報 KORU Medical Systems Inc 企業名
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
企業情報
企業コードKRMD
会社名KORU Medical Systems Inc
上場日Oct 27, 1993
最高経営責任者「CEO」Ms. Linda M. Tharby
従業員数80
証券種類Ordinary Share
決算期末Oct 27
本社所在地100 Corporate Drive
都市MAHWAH
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号07430
電話番号18454692042
ウェブサイトhttps://www.korumedical.com/
企業コードKRMD
上場日Oct 27, 1993
最高経営責任者「CEO」Ms. Linda M. Tharby
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
会社名
収益
比率
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
地域別USD
会社名
収益
比率
Domestic
7.21M
74.79%
International
2.43M
25.21%
事業別
地域別
事業別USD
会社名
収益
比率
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
Horton Capital Management LLC
12.70%
First Light Asset Management, LLC
10.13%
Topline Capital Management, LLC
7.80%
Tharby (Linda M)
4.52%
The Vanguard Group, Inc.
4.51%
他の
60.34%
株主統計
株主統計
比率
Horton Capital Management LLC
12.70%
First Light Asset Management, LLC
10.13%
Topline Capital Management, LLC
7.80%
Tharby (Linda M)
4.52%
The Vanguard Group, Inc.
4.51%
他の
60.34%
種類
株主統計
比率
Hedge Fund
23.51%
Investment Advisor/Hedge Fund
17.47%
Investment Advisor
13.19%
Individual Investor
8.29%
Pension Fund
0.92%
Research Firm
0.47%
Bank and Trust
0.09%
Insurance Company
0.03%
他の
36.03%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
2023Q1
149
31.99M
70.39%
-2.55M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Horton Capital Management LLC
5.87M
12.73%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.71M
10.22%
+259.46K
+5.82%
Apr 30, 2025
Topline Capital Management, LLC
3.82M
8.28%
-505.93K
-11.69%
Mar 31, 2025
Tharby (Linda M)
2.09M
4.53%
+293.63K
+16.34%
Apr 21, 2025
The Vanguard Group, Inc.
1.76M
3.82%
+6.48K
+0.37%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
181.51K
0.39%
-323.00
-0.18%
Mar 31, 2025
Geode Capital Management, L.L.C.
495.27K
1.07%
+32.09K
+6.93%
Mar 31, 2025
Meros Investment Management, LP
746.56K
1.62%
-18.99K
-2.48%
Mar 31, 2025
Archon Capital Management LLC
566.87K
1.23%
+377.97K
+200.09%
Mar 31, 2025
Manko (Joseph M JR)
517.20K
1.12%
--
--
Apr 02, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI